Universe Pharmaceuticals (UPC) Debt Ratio (2020 - 2025)

Universe Pharmaceuticals' (UPC) quarterly Debt Ratio came in at 0.03 in Q3 2025, down 74.16% year-on-year from 0.12 in Q3 2024, and down 74.16% quarter-over-quarter from 0.12 in Q3 2024.

Universe Pharmaceuticals (UPC) Debt Ratio (2020 - 2025) Analysis & Trends

Universe Pharmaceuticals has disclosed Debt Ratio across 6 years of filings, most recently posting 0.03 for Q3 2025.

  • Debt Ratio for Q3 2025 came in at 0.03, down 74.16% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.03 (down 74.16% YoY), and the FY2025 annual result was 0.03, down 74.16% from the prior year.
  • Debt Ratio came in at 0.03 for Q3 2025 at Universe Pharmaceuticals, down from 0.12 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.15 in Q1 2024 to a low of 0.0 in Q1 2022.
  • The 5-year median for Debt Ratio is 0.07 (2022), against an average of 0.07.
  • Across the five-year window, Debt Ratio slumped 100.0% in 2021 and jumped 75586.58% in 2023, its largest moves.
  • Universe Pharmaceuticals' Debt Ratio stood at 0.0 in 2021, then jumped by 20085.36% to 0.06 in 2022, then jumped by 131.51% to 0.13 in 2023, then declined by 10.47% to 0.12 in 2024, then slumped by 74.16% to 0.03 in 2025.
  • The last three Debt Ratio figures came in at 0.03 (Q3 2025), 0.12 (Q3 2024), and 0.15 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.42
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.60
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.01
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.30
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.35
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.24
10 Universe Pharmaceuticals - - - 0.03

Historic Data

Download Data
DateValue
Sep 30, 2025 0.03
Sep 30, 2024 0.12
Mar 31, 2024 0.15
Sep 30, 2023 0.13
Mar 31, 2023 0.08
Sep 30, 2022 0.06
Mar 31, 2022 0.00
Sep 30, 2021 0.00
Sep 30, 2020 33.21 Bn